FIELD: medicine, oncology. SUBSTANCE: product: agent has nonapeptide DSIP of the following amino acids sequence: Trp-Ala-Gly-Gly-Asp-Ala-Ser-Gly-Glu, dipeptide carnosine and amino acid glycine at the following ratio of components = 1: (1-100):(1-100), respectively. Agent enhances organism resistance to toxic compounds and irradiation, decreases toxic syndrome at toxic and viral hepatitis. EFFECT: enhanced effectiveness of agent.
Authors
Dates
1997-07-20—Published
1995-08-10—Filed